Found 5 matching trials
Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old
PHASE2This study is designed to characterize the safety and immunogenicity of pan...
Location
GSK Investigational Site
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
PHASE1This study is designed to characterize the safety and immunogenicity of a' ...
Location
GSK Investigational Site
Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children
PHASE2The objective of this study is to evaluate the immunogenicity and safety of...
Location
GSK Investigational Site
Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years
PHASE2The purpose of this study is to show that vaccination with a single dose of...
Location
GSK Investigational Site
Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults
PHASE2This study is designed to characterize the safety and immunogenicity of a' ...
Location
Multiple Locations